NCT05516914 2026-04-01
A Phase Ib/II Clinical Trial of LBL-007 Combined With Tislelizumab in the Treatment of Malignant Tumors
Nanjing Leads Biolabs Co.,Ltd
Phase 1/2 Completed
Nanjing Leads Biolabs Co.,Ltd
LaNova Medicines Limited
Chinese PLA General Hospital
Qilu Pharmaceutical Co., Ltd.